insights_auto
Why is INO down 10,49%?
Dive Deeperchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,45 $
arrow_downward
-10,49%(-0,17) 1D
1,23 $
arrow_downward
-15,17% (-0,22)bedtimeAfter hours
Closed: 5 қар., 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,57 $
High
1,59 $
Low
1,40 $
Mkt. cap
149,93 млн
Avg. vol.
15,72 млн
Volume
16,11 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
Open
1,57 $
High
1,59 $
Low
1,40 $
Mkt. cap
149,93 млн
Avg. vol.
15,72 млн
Volume
16,11 млн
52-wk high
2,72 $
52-wk low
0,57 $
EPS
-1,17 $
Beta
1,71
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
News Corp
·
34 минут бұрын
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Investing.com
·
1 сағат бұрын
Inovio announces proposed public offering of common stock
TradingView
·
1 сағат бұрын
INOVIO Pharmaceuticals announces proposed public offering; shares tumble
Benzinga
·
1 сағат бұрын
12 Health Care Stocks Moving In Thursday's After-Market Session
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc